AskTheDate.com
Back to calendar

Spero Therapeutics, Inc. (SPRO) Earnings

SPRO reports earnings on Monday, November 16, 2026

earnings report
November 16, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.47
Actual EPS: $-0.16
EPS surprise: 5.88%
Company overview
Market Cap$60.9M
PriceUSD 1.04
P/E9.57
EPS (TTM)0.11
52-week high3.08
52-week low1.03
SectorHealth Technology
IndustryBiotechnology
Employees25
Buy me a coffee